IGM Biosciences Inc

IGMS

Market Cap$340.4M

Close$

Compare IGM Biosciences

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
IGM Biosciences Inc	-1.4	0%	-147%	-	0.3
Market Avg	54.3	1.27%	32%	-	1.3
Healthcare Avg	39.1	1.36%	17%	7.2	1.3

$20.00

Target Price by Analysts

114.1% upsideIGM Biosciences Target Price Details

$0.79

Current Fair Value

91.5% downside

Overvalued by 91.5% based on the discounted cash flow analysis.

Share Statistics

Market cap	$340.40 Million
Enterprise Value	$87.56 Million
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-4.71
Beta	1.48
Outstanding Shares	33,636,592
Avg 30 Day Volume	306,037

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-1.38
PEG	8.63
Price to Sales	-
Price to Book Ratio	2.34
Enterprise Value to Revenue	41.6
Enterprise Value to EBIT	-0.34
Enterprise Value to Net Income	-1
Total Debt to Enterprise	0.47
Debt to Equity	0.25

Revenue Sources

No data

ESG Score

No data

About IGM Biosciences Inc